Categories AlphaGraphs, Earnings, Technology
Twitter beats Q2 revenue estimates but earnings miss mark
Twitter Inc. (NYSE: TWTR) topped revenue estimates for the second quarter of 2019 but earnings missed expectations. Shares gained 5.2% in premarket hours on Friday.
Total revenue rose 18% year-over-year to $841 million, beating analysts’ estimates of $829 million. The results also exceeded the company’s guidance of $770-830 million, mainly driven by strength in US advertising.
On a GAAP basis, net income was $1.1 billion, or $1.43 per share, compared to $100 million, or $0.13 per share, in the year-ago quarter. The results include a significant income tax benefit related to the establishment of a deferred tax asset. Adjusted net income totaled $37 million, or $0.05 per share, below the forecasts for $0.19 per share.
Total advertising revenue grew 21% to $727 million, helped by double-digit increases in both domestic and international ad revenue. Data licensing and other revenue rose 4% to $114 million.
Revenue in the US increased 24% to $455 million while international revenue increased 12% to $386 million. Japan remains Twitter’s second largest market, growing 9% year-over-year, and contributing 16% of total revenue during the period.
Average monetizable daily active usage (mDAU) was 139 million, up 14% year-over-year, helped by organic growth, product improvements and marketing. Average mDAU rose 10% in the US and 15% internationally.
Video continues to be an important part of Twitter’s offerings. The company announced a number of live and on-demand video content partnerships across the news, sports and entertainment verticals during the quarter. Twitter was able to renew its existing partnerships as well as strike new alliances with prominent partners in this space.
Twitter is also making progress in its efforts to reduce toxic content on its platform. During the quarter, the company reported an 18% decline in spammy or suspicious content on its website.
For the third quarter of 2019, Twitter expects total revenue of $815-875 million. For the full year of 2019, the company expects capital expenditures to be between $550 million and $600 million.
Listen to on-demand earnings calls and hear how management responds to analysts’ questions
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on